DNA (STOCKS)
Ginkgo Bioworks Holdings, Inc.
$6.680000
+0.230000 (+3.57%)
Prev close: $6.450000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Jason Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $410.48M
- Employees
- 834
- P/E (TTM)
- -1.18
- P/B (TTM)
- 0.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
1
Buy
2
Hold
5
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.41 | $-1.47 | +0.0596 | +4.06% |
|
Sep 2025 (Q3)
|
$-1.45 | $-1.25 | -0.1976 | -15.78% |
|
Jun 2025 (Q2)
|
$-1.10 | $-1.58 | +0.4823 | +30.48% |
|
Mar 2025 (Q1)
|
$-1.68 | $-1.79 | +0.1077 | +6.02% |
Financial Statements
| Revenues | $170.16M |
| Benefits Costs and Expenses | $483.76M |
| Costs And Expenses | $483.76M |
| Operating Expenses | $485.43M |
| Depreciation and Amortization | $58.99M |
| Research and Development | $243.77M |
| Other Operating Expenses | $182.67M |
| Operating Income/Loss | -$315.28M |
| Income/Loss Before Equity Method Investments | -$313.60M |
| Income/Loss From Continuing Operations After Tax | -$312.76M |
| Income/Loss From Continuing Operations Before Tax | -$313.60M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | -$837.00K |
| Income Tax Expense/Benefit, Current | $527.00K |
| Income Tax Expense/Benefit, Deferred | -$1.36M |
| Net Income/Loss | -$312.76M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$312.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$312.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.64 |
| Diluted Earnings Per Share | -$5.64 |
| Basic Average Shares | 55,457,676 |
| Diluted Average Shares | 55,457,676 |
| Assets | $1.12B |
| Current Assets | $471.84M |
| Noncurrent Assets | $647.86M |
| Fixed Assets | $167.78M |
| Intangible Assets | $56.92M |
| Other Non-current Assets | $423.15M |
| Liabilities | $611.11M |
| Current Liabilities | $95.97M |
| Accounts Payable | $10.57M |
| Wages | $4.26M |
| Other Current Liabilities | $81.15M |
| Noncurrent Liabilities | $515.14M |
| Equity | $508.59M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $508.59M |
| Liabilities And Equity | $1.12B |
| Net Cash Flow From Operating Activities | -$171.06M |
| Net Cash Flow From Operating Activities, Continuing | -$171.06M |
| Net Cash Flow From Investing Activities | -$240.29M |
| Net Cash Flow From Investing Activities, Continuing | -$240.29M |
| Net Cash Flow From Financing Activities | $17.78M |
| Net Cash Flow From Financing Activities, Continuing | $17.78M |
| Exchange Gains/Losses | $201.00K |
| Net Cash Flow | -$393.37M |
| Net Cash Flow, Continuing | -$393.57M |
| Comprehensive Income/Loss | -$309.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$309.11M |
| Other Comprehensive Income/Loss | $3.66M |
| Other Comprehensive Income/Loss Attributable To Parent | $3.66M |